The immunological mechanisms involved in maintenance of an asymptomatic microfilaremic
state (MF) in patients with lymphatic filariasis remain undefined. MF patients have impaired …

Individuals residing in malaria-endemic regions acquire protective immunity after repeated
infection with malaria parasites; however, mechanisms of protective immunity and their …

Malaria therapy, experimental, and epidemiological studies have shown that erythrocyte
Duffy blood group-negative people, largely of African ancestry, are resistant to erythrocyte …

Background The World Health Organization has targeted lymphatic filariasis for global
elimination by 2020 with a strategy of mass drug administration. This trial tested whether a single …

Plasmodium vivax (Pv) is a major cause of human malaria and is increasing in public health
importance compared with falciparum malaria. Pv is unique among human malarias in that …

Infants and children are routinely vaccinated with bacillus Calmette-Guérin (BCG) in areas of
the world where worm infections are common. Because maternal helminth infection during …

Substantial evidence indicates that antibodies to Plasmodium falciparum merozoite antigens
play a role in protection from malaria, although the precise targets and mechanisms …

The development of effective malaria vaccines and immune biomarkers of malaria is a high
priority for malaria control and elimination. Ags expressed by merozoites of Plasmodium …

Background Plasmodium vivax invasion requires interaction between the human Duffy antigen
on the surface of erythrocytes and the P. vivax Duffy binding protein (PvDBP) expressed …

Human neonates are generally deficient in their ability to generate humoral immunity. This
deficiency is thought to reflect physiologic immaturity of T and B cell function and lack of …